Correlations between Diffusion Tensor Imaging (DTI) and Magnetic Resonance Spectroscopy (1H MRS) in schizophrenic patients and normal controls

BMC Psychiatry

Volumn 7, Issue , 2007, Pages

  Tang, Cheuk Y ^a   Friedman, Joseph ^a   Shungu, Dikoma ^b   Chang, Linda ^c   Ernst, Thomas ^c   Stewart, Daniel ^a   Hajianpour, Arash ^a   Carpenter, David ^a   Ng, Johnny ^a   Mao, Xiangling ^b   Hof, Patrick R ^a   Buchsbaum, Monte S ^a   Davis, Kenneth ^a   Gorman, Jack M ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c UNIVERSITY OF HAWAII   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; CLOZAPINE; N ACETYLASPARTIC ACID; OLANZAPINE; QUETIAPINE; RISPERIDONE; ZIPRASIDONE;

ADULT; AGED; ANISOTROPY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIFFUSION TENSOR IMAGING; FEMALE; HUMAN; IMAGE ANALYSIS; IMAGE DISPLAY; IMAGE PROCESSING; IMAGE QUALITY; MALE; OCCIPITAL LOBE; PREFRONTAL CORTEX; PROTON NUCLEAR MAGNETIC RESONANCE; SCHIZOPHRENIA; TEMPORAL LOBE; WHITE MATTER; ADOLESCENT; BRAIN; CLINICAL TRIAL; DIFFUSION WEIGHTED IMAGING; HOSPITAL PATIENT; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OUTPATIENT; PATHOLOGY; PSYCHOSIS; REFERENCE VALUE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BRAIN; DIFFUSION MAGNETIC RESONANCE IMAGING; HUMANS; INPATIENTS; MAGNETIC RESONANCE SPECTROSCOPY; MIDDLE AGED; OUTPATIENTS; PREFRONTAL CORTEX; PSYCHOTIC DISORDERS; REFERENCE VALUES; SCHIZOPHRENIA;

EID: 34547207179     PISSN: None     EISSN: 1471244X     Source Type: Journal    
DOI: 10.1186/1471-244X-7-25     Document Type: Article

References (80)

1. Benes FM Emerging principles of altered neural circuitry in schizophrenia Brain Res Brain Res Rev 2000 31 251 269 10.1016/ S0165-0173(99)00041-7 10719152
2. Bunney WE Bunney BG Evidence for a compromised dorsolateral prefrontal cortical parallel circuit in schizophrenia Brain Res Brain Res Rev 2000 31 138 146 10.1016/S0165-0173(99)00031-4 10719142
3. Carlsson A Waters N Holm-Waters S Tedroff J Nilsson M Carlsson ML Interactions between monoamines, glutamate, and GABA in schizophrenia: new evidence Annu Rev Pharmacol Toxicol 2001 41 237 260 10.1146/ annurev.pharmtox.41.1.237 11264457
4. Grace AA Gating of information flow within the limbic system and the pathophysiology of schizophrenia Brain Res Brain Res Rev 2000 31 330 341 10.1016/S0165-0173(99)00049-1 10719160
5. Heimer L Basal forebrain in the context of schizophrenia Brain Res Brain Res Rev 2000 31 205 235 10.1016/S0165-0173(99)00039-9 10719150
6. Middleton FA Strick PL Basal ganglia and cerebellar loops: Motor and cognitive circuits Brain Res Brain Res Rev 2000 31 236 250 10.1016/ S0165-0173(99)00040-5 10719151
7. Selemon LD Rajkowska G Goldman-Rakic PS Elevated neuronal density in prefrontal area 46 in brains from schizophrenic patients: Application of a three-dimensional, stereologic counting method J Comp Neurol 1998 392 402 412 10.1002/ (SICI)1096-9861(19980316)392:3<402::AID-CNE9>3.0.CO;2-5 9511926
8. Selemon LD Rajkowska G Goldman-Rakic PS Abnormally high neuronal density in the schizophrenic cortex. A morphometric analysis of prefrontal area 9 and occipital area 17 Arch Gen Psychiatry 1995 52 805 18; discussion 819-20 7575100
9. Pakkenberg B Total nerve cell number in neocortex in chronic schizophrenics and controls estimated using optical disectors Biol Psychiatry 1993 34 768 772 10.1016/0006-3223(93)90065-L 8292680
10. Williams RW Rakic P Elimination of neurons from the rhesus monkey's lateral geniculate nucleus during development J Comp Neurol 1988 272 424 436 10.1002/cne.902720310 3417894
11. Selemon LD Goldman-Rakic PS The reduced neuropil hypothesis: A circuit based model of schizophrenia Biol Psychiatry 1999 45 17 25 10.1016/ S0006-3223(98)00281-9 9894571
12. Davis SR Lewis DA Local circuit neurons of the prefrontal cortex in schizophrenia: Selective increase in the density of calbindin-immunoreactive neurons Psychiatry Res 1995 59 81 96 10.1016/ 0165-1781(95)02720-3 8771223
13. Akbarian S Kim JJ Potkin SG Hetrick WP Bunney WE Jr. Jones EG Maldistribution of interstitial neurons in prefrontal white matter of the brains of schizophrenic patients Arch Gen Psychiatry 1996 53 425 436 8624186
14. Wright IC Rabe-Hesketh S Woodruff PW David AS Murray RM Bullmore ET Meta-analysis of regional brain volumes in schizophrenia Am J Psychiatry 2000 157 16 25 10618008
15. Cannon TD van Erp TG Huttunen M Lonnqvist J Salonen O Valanne L Poutanen VP Standertskjold-Nordenstam CG Gur RE Yan M Regional gray matter, white matter, and cerebrospinal fluid distributions in schizophrenic patients, their siblings, and controls Arch Gen Psychiatry 1998 55 1084 1091 10.1001/archpsyc.55.12.1084 9862551
16. Foong J Maier M Barker GJ Brocklehurst S Miller DH Ron MA In vivo investigation of white matter pathology in schizophrenia with magnetisation transfer imaging J Neurol Neurosurg Psychiatry 2000 68 70 74 10.1136/jnnp.68.1.70 10601405
17. Breier A Buchanan RW Elkashef A Munson RC Kirkpatrick B Gellad F Brain morphology and schizophrenia. A magnetic resonance imaging study of limbic, prefrontal cortex, and caudate structures Arch Gen Psychiatry 1992 49 921 926 1449382
18. Sigmundsson T Suckling J Maier M Williams S Bullmore E Greenwood K Fukuda R Ron M Toone B Structural abnormalities in frontal, temporal, and limbic regions and interconnecting white matter tracts in schizophrenic patients with prominent negative symptoms Am J Psychiatry 2001 158 234 243 10.1176/appi.ajp.158.2.234 11156806
19. Buchanan RW Vladar K Barta PE Pearlson GD Structural evaluation of the prefrontal cortex in schizophrenia Am J Psychiatry 1998 155 1049 1055 9699693
20. Sanfilipo M Lafargue T Rusinek H Arena L Loneragan C Lautin A Feiner D Rotrosen J Wolkin A Volumetric measure of the frontal and temporal lobe regions in schizophrenia: Relationship to negative symptoms Arch Gen Psychiatry 2000 57 471 480 10.1001/archpsyc.57.5.471 10807487
21. Foong J Symms MR Barker GJ Maier M Woermann FG Miller DH Ron MA Neuropathological abnormalities in schizophrenia: Evidence from magnetization transfer imaging Brain 2001 124 882 892 10.1093/brain/ 124.5.882 11335691
22. Maier M Mellers J Toone B Trimble M Ron MA Schizophrenia, temporal lobe epilepsy and psychosis: An in vivo magnetic resonance spectroscopy and imaging study of the hippocampus/amygdala complex Psychol Med 2000 30 571 581 10.1017/S0033291799001993 10883713
23. Bertolino A Esposito G Callicott JH Mattay VS Van Horn JD Frank JA Berman KF Weinberger DR Specific relationship between prefrontal neuronal N-acetylaspartate and activation of the working memory cortical network in schizophrenia Am J Psychiatry 2000 157 26 33 10618009
24. Rowland L Bustillo JR Lauriello J Proton magnetic resonance spectroscopy (H-MRS) studies of schizophrenia Semin Clin Neuropsychiatry 2001 6 121 130 10.1053/scnp.2001.21838 11296312
25. Cecil KM Lenkinski RE Gur RE Gur RC Proton magnetic resonance spectroscopy in the frontal and temporal lobes of neuroleptic naive patients with schizophrenia Neuropsychopharmacology 1999 20 131 140 10.1016/S0893-133X(98)00063-3 9885793
26. Yurgelun-Todd DA Renshaw PF Gruber SA Waternaux C Cohen BM Proton magnetic resonance spectroscopy of the temporal lobes in schizophrenics and normal controls Schizophrenia Research 1996 19 55 59 10.1016/ 0920-9964(95)00071-2 9147496
27. Fukuzako H Kodama S Fukuzako T Yamada K Doi W Sato D Takigawa M Subtype-associated metabolite differences in the temporal lobe in schizophrenia detected by proton magnetic resonance spectroscopy Psychiatry Res 1999 92 45 56 10.1016/S0925-4927(99)00035-9 10688159
28. Buchsbaum MS Tang CY Peled S Gudbjartsson H Lu D Hazlett EA Downhill J Haznedar M Fallon J MRI white matter diffusion anisotropy and PET metabolic rate in Schizophrenia Neuroreport 1998 9 425 430 10.1097/ 00001756-199802160-00013 9512384
29. Lim KO Hedehus M Moseley M de Crespigny A Sullivan EV Pfefferbaum A Compromised white matter tract integrity in schizophrenia inferred from diffusion tensor imaging Arch Gen Psychiatry 1999 56 367 374 10.1001/ archpsyc.56.4.367 10197834
30. Kalus P Buri C Slotboom J Gralla J Remonda L Dierks T Strik WK Schroth G Kiefer C Volumetry and diffusion tensor imaging of hippocampal subregions in schizophrenia Neuroreport 2004 15 867 871 10.1097/ 00001756-200404090-00027 15073533
31. Kubicki M Westin CF Nestor PG Wible CG Frumin M Maier SE Kikinis R Jolesz FA McCarley RW Shenton ME Cingulate fasciculus integrity disruption in schizophrenia: A magnetic resonance diffusion tensor imaging study Biological Psychiatry 2003 54 1171 1180 10.1016/ S0006-3223(03)00419-0 14643084
32. Ardekani BA Nierenberg J Hoptman MJ Javitt DC Lim KO MRI study of white matter diffusion anisotropy in schizophrenia Neuroreport 2003 14 2025 2029 10.1097/00001756-200311140-00004 14600491
33. Lim KO Helpern JA Neuropsychiatric applications of DTI - a review NMR Biomed 2002 15 587 593 10.1002/nbm.789 12489105
34. Foong J Maier M Clark CA Barker GJ Miller DH Ron MA Neuropathological abnormalities of the corpus callosum in schizophrenia: A diffusion tensor imaging study J Neurol Neurosurg Psychiatry 2000 68 242 244 10.1136/jnnp.68.2.242 10644799
35. Urenjak J Williams SR Gadian DG Noble M Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types J Neurosci 1993 13 981 989 8441018
36. Arnold DL Matthews PM Francis GS O'Connor J Antel JP Proton magnetic resonance spectroscopic imaging for metabolic characterization of demyelinating plaques Ann Neurol 1992 31 235 241 10.1002/ana.410310302 1637131
37. Deicken RF Feiwell R Schuff N Soher B Evidence for altered cerebellar vermis neuronal integrity in schizophrenia Psychiatry Res 2001 107 125 134 10.1016/S0925-4927(01)00103-2 11566429
38. Auer DP Wilke M Grabner A Heidenreich JO Bronisch T Wetter TC Reduced NAA in the thalamus and altered membrane and glial metabolism in schizophrenic patients detected by 1H-MRS and tissue segmentation Schizophr Res 2001 52 87 99 10.1016/S0920-9964(01)00155-4 11595395
39. Ende G Braus DF Walter S Henn FA Lower concentration of thalamic n-acetylaspartate in patients with schizophrenia: A replication study Am J Psychiatry 2001 158 1314 1316 10.1176/appi.ajp.158.8.1314 11481168
40. Omori M Murata T Kimura H Koshimoto Y Kado H Ishimori Y Ito H Wada Y Thalamic abnormalities in patients with schizophrenia revealed by proton magnetic resonance spectroscopy Psychiatry Res 2000 98 155 162 10.1016/ S0925-4927(00)00049-4 10821998
41. Deicken RF Johnson C Eliaz Y Schuff N Reduced concentrations of thalamic N-acetylaspartate in male patients with schizophrenia Am J Psychiatry 2000 157 644 647 10.1176/appi.ajp.157.4.644 10739431
42. Bertolino A Callicott JH Mattay VS Weidenhammer KM Rakow R Egan MF Weinberger DR The effect of treatment with antipsychotic drugs on brain N-acetylaspartate measures in patients with schizophrenia Biol Psychiatry 2001 49 39 46 10.1016/S0006-3223(00)00997-5 11163778
43. Callicott JH Bertolino A Mattay VS Langheim FJ Duyn J Coppola R Goldberg TE Weinberger DR Physiological dysfunction of the dorsolateral prefrontal cortex in schizophrenia revisited Cereb Cortex 2000 10 1078 1092 10.1093/cercor/10.11.1078 11053229
44. Bertolino A Breier A Callicott JH Adler C Mattay VS Shapiro M Frank JA Pickar D Weinberger DR The relationship between dorsolateral prefrontal neuronal N-acetylaspartate and evoked release of striatal dopamine in schizophrenia Neuropsychopharmacology 2000 22 125 132 10.1016/ S0893-133X(99)00096-2 10649825
45. Ende G Braus DF Walter S Weber-Fahr W Soher B Maudsley AA Henn FA Effects of age, medication, and illness duration on the N-acetyl aspartate signal of the anterior cingulate region in schizophrenia Schizophr Res 2000 41 389 395 10.1016/S0920-9964(99)00089-4 10728716
46. Szulc A Galinska B Tarasow E Walecki J Dzienis W Kubas B Czernikiewicz A [Clinical and neuropsychological correlates of proton magnetic resonance spectroscopy detected metabolites in brains of first-episode and schizophrenic patients] Psychiatr Pol 2003 37 977 988 14727370
47. Fukuzako H Takeuchi K Hokazono Y Fukuzako T Yamada K Hashiguchi T Obo Y Ueyama K Takigawa M Fujimoto T Proton magnetic resonance spectroscopy of the left medial temporal and frontal lobes in chronic schizophrenia: preliminary report Psychiatry Res 1995 61 193 200 10.1016/ 0925-4927(95)02622-5 8748464
48. Bitsch A Bruhn H Vougioukas V Stringaris A Lassmann H Frahm J Bruck W Inflammatory CNS Demyelination: Histopathologic Correlation with In Vivo Quantitative Proton MR Spectroscopy AJNR Am J Neuroradiol 1999 20 1619 1627 10543631
49. Basser PJ Inferring Microstructural features and the Physiological State of Tissues from Diffusion Weighted Images NMR in Biomedicine 1995 8 333 344 10.1002/nbm.1940080707 8739270
50. Basser PJ New histological and physiological stains derived from diffusion-tensor MR images Ann N Y Acad Sci 1997 820 123 138 10.1111/ j.1749-6632.1997.tb46192.x 9237452
51. Basser PJ Pierpaoli C Microstructural and Physiological Features of Tissues Elucidated by Quantitative-Diffusion-Tensor MRI Journal of Magnetic Resonance, Series B 1996 111 3 209 219 10.1006/jmrb.1996.0086
52. Pierpaoli C Jezzard P Basser PJ Barnett A Chiro GD Diffusion Tensor MR Imaging of the Human Brain Radiology 1996 201 637 648 8939209
53. Pierpaoli C Basser PJ Toward a Quantitative Assessment of Diffusion Anisotropy Magnetic Resonance in Medicine 1996 36 893 906 10.1002/ mrm.1910360612 8946355
54. Mori S van Zijl PC Fiber tracking: Principles and strategies - a technical review NMR Biomed 2002 15 468 480 10.1002/nbm.781 12489096
55. Bammer R Acar B Moseley ME In vivo MR tractography using diffusion imaging European Journal of Radiology 2003 45 223 234 10.1016/ S0720-048X(02)00311-X 12595107
56. Conturo TE Lori NF Cull TS Akbudak E Snyder AZ Shimony JS McKinstry RC Burton H Raichle ME Tracking neuronal fiber pathways in the living human brain Proc Natl Acad Sci 1999 96 10422 10427 17904 10468624 10.1073/ pnas.96.18.10422
57. Wolkin A Choi SJ Szilagyi S Sanfilipo M Rotrosen JP Lim KO Inferior frontal white matter anisotropy and negative symptoms of schizophrenia: a diffusion tensor imaging study Am J Psychiatry 2003 160 572 574 10.1176/appi.ajp.160.3.572 12611842
58. Hoptman MJ Volavka J Johnson G Weiss E Bilder RM Lim KO Frontal white matter microstructure, aggression, and impulsivity in men with schizophrenia: A preliminary study Biological Psychiatry 2002 52 9 14 10.1016/S0006-3223(02)01311-2 12079725
59. Sun Z Wang F Cui L Breeze J Du X Wang X Cong Z Zhang H Li B Hong N Zhang D Abnormal anterior cingulum in patients with schizophrenia: A diffusion tensor imaging study Neuroreport 2003 14 1833 1836 10.1097/ 00001756-200310060-00015 14534430
60. Spalletta G Tomaiuolo F Marino V Bonaviri G Trequattrini A Caltagirone C Chronic schizophrenia as a brain misconnection syndrome: A white matter voxel-based morphometry study Schizophrenia Research 2003 64 15 23 10.1016/S0920-9964(03)00010-0 14511797
61. Agartz I Andersson JL Skare S Abnormal brain white matter in schizophrenia: A diffusion tensor imaging study Neuroreport 2001 12 2251 2254 10.1097/00001756-200107200-00041 11447344
62. Andreasen NC Flaum M Arndt S The Comprehensive Assessment of Symptoms and History (CASH). An instrument for assessing diagnosis and psychopathology Arch Gen Psychiatry 1992 49 615 623 1637251
63. Pfefferbaum A Sullivan EV Hedehus M Lim KO Adalsteinsson E Moseley M Age-related decline in brain white matter anisotropy measured with spatially corrected echo-planar diffusion tensor imaging Magn Reson Med 2000 44 259 268 10.1002/ 1522-2594(200008)44:2<259::AID-MRM13>3.0.CO;2-6 10918325
64. Nusbaum AO Tang CY Buchsbaum MS Wei TC Atlas SW Regional and global changes in cerebral diffusion with normal aging AJNR Am J Neuroradiol 2001 22 136 142 11158899
65. Saunders DE Howe FA van den Boogaart A Griffiths JR Brown MM Aging of the adult human brain: In vivo quantitation of metabolite content with proton magnetic resonance spectroscopy J Magn Reson Imaging 1999 9 711 716 10.1002/(SICI)1522-2586(199905)9:5<711::AID-JMRI14>3.0.CO;2-3 10331768
66. Miller BL A review of chemical issues in 1H NMR spectroscopy: N-acetyl-L-aspartate, creatine and choline NMR Biomed 1991 4 47 52 10.1002/nbm.1940040203 1650241
67. Uren jak J Williams SR Gadian DG Noble M Specific expression of N-acetylaspartate in neurons, oligodendrocyte-type-2 astrocyte progenitors, and immature oligodendrocytes in vitro J Neurochem 1992 59 55 61 10.1111/j.1471-4159.1992.tb08875.x 1613513
68. Meyerhoff DJ MacKay S Bachman L Poole N Dillon WP Weiner MW Fein G Reduced brain N-acetylaspartate suggests neuronal loss in cognitively impaired human immunodeficiency virus-seropositive individuals: In vivo 1H magnetic resonance spectroscopic imaging Neurology 1993 43 509 515 8450992
69. Lu ZH Chakraborty G Ledeen RW Yahya D Wu G N-Acetylaspartate synthase is bimodally expressed in microsomes and mitochondria of brain Molecular Brain Research 2004 122 71 78 10.1016/j.molbrainres.2003.12.002 14992817
70. Arnett HA Fancy SP Alberta JA Zhao C Plant SR Kaing S Raine CS Rowitch DH Franklin RJ Stiles CD bHLH transcription factor Olig1 is required to repair demyelinated lesions in the CNS Science 2004 306 2111 2115 10.1126/science.1103709 15604411
71. Chang A Tourtellotte WW Rudick R Trapp BD Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis N Engl J Med 2002 346 165 173 10.1056/NEJMoa010994 11796850
72. Mulkern RV Zengingonul HP Robertson RL Bogner P Zou KH Gudbjartsson H Guttmann CR Holtzman D Kyriakos W Jolesz FA Maier SE Multi-component apparent diffusion coefficients in human brain: Relationship to spin-lattice relaxation Magn Reson Med 2000 44 292 300 10.1002/ 1522-2594(200008)44:2<292::AID-MRM17>3.0.CO;2-Q 10918329
73. Mulkern RV Gudbjartsson H Westin CF Zengingonul HP Gartner W Guttmann CR Robertson RL Kyriakos W Schwartz R Holtzman D Jolesz FA Maier SE Multi-component apparent diffusion coefficients in human brain NMR Biomed 1999 12 51 62 10.1002/ (SICI)1099-1492(199902)12:1<51::AID-NBM546>3.0.CO;2-E 10195330
74. Beaulieu C The basis of anisotropic water diffusion in the nervous system - a technical review NMR Biomed 2002 15 435 455 10.1002/nbm.782 12489094
75. Le Bihan D Mangin JF Poupon C Clark CA Pappata S Molko N Chabriat H Diffusion tensor imaging: Concepts and applications J Magn Reson Imaging 2001 13 534 546 10.1002/jmri.1076 11276097
76. Steen RG Hamer RM Lieberman JA Measurement of brain metabolites by 1H magnetic resonance spectroscopy in patients with schizophrenia: A systematic review and meta-analysis Neuropsychopharmacology 2005 30 1949 1962 10.1038/sj.npp.1300850 16123764
77. Buchsbaum MS Friedman J Buchsbaum BR Chu KW Hazlett EA Newmark R Schneiderman JS Torosjan Y Tang C Hof PR Stewart D Davis KL Gorman J Diffusion Tensor Imaging in Schizophrenia Biol Psychiatry 2006 16893533
78. Steel RM Bastin ME McConnell S Marshall I Cunningham-Owens DG Lawrie SM Johnstone EC Best JJK Diffusion tensor imaging (DTI) and proton magnetic resonance spectroscopy (1H MRS) in schizophrenic subjects and normal controls Psychiatry Research: Neuroimaging 2001 106 3 161 170 10.1016/ S0925-4927(01)00080-4
79. Irwan R Sijens PE Potze JH Oudkerk M Correlation of proton MR spectroscopy and diffusion tensor imaging Magn Reson Imaging 2005 23 851 858 10.1016/j.mri.2005.06.005 16275423
80. Sijens PE Irwan R Potze JH Mostert JP De Keyser J Oudkerk M Analysis of the human brain in primary progressive multiple sclerosis with mapping of the spatial distributions using (1)H MR spectroscopy and diffusion tensor imaging Eur Radiol 2005 15 1686 1693 10.1007/s00330-005-2775-0 15846494